Skip to content

Study · Animal study (in vivo) · mouse · 1994

3 results

Resistance to pseudorabies virus with enhanced interferon production and natural killer cell activity in mice treated with serum thymic factor.

Onodera T, Yoshihara K, Suzuki T, Tsuda T, Ikeda T, Awaya A, Kobayashi H, Yukawa M

Microbiology and immunology1 Jan 1994Cited by 7 (Europe PMC)

PMID7519717 (opens in a new tab)DOI10.1111/j.1348-0421.1994.tb01743.x (opens in a new tab)PepBankPUB-07519717
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In PRV-infected mice, mortality after FTS pretreatment was significantly lower than in controls.

    In plain wordsIn mice infected with PRV, FTS pretreatment reduced deaths compared with controls.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    DecreaseMortality after PRV infection
    Study

    mousen: not reported in source

    PRV-infected mice
    Comparator
    controls
    Outcome group
    Mortality · Whole body
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In mice with depleted NK cell activity, the mortality of PRV-infected mice was markedly high, whereas that of FTS-pretreated mice was significantly lower than the controls.
    1 context sentence
    Summary · context
    Effects of serum thymic factor (FTS) on susceptibility of mice to PRV were also investigated.
  2. 02AnimalAnimal study (in vivo)Mechanism

    In mice studied for FTS-induced resistance to PRV, FTS pretreatment enhanced interferon production.

    In plain wordsIn mice studied for resistance to PRV, FTS pretreatment increased interferon production.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    IncreaseInterferon production
    Study

    mousen: not reported in source

    PRV-infected mice
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Interferon production and NK cell activity were enhanced in the FTS-pretreated mice
    1 context sentence
    Summary · context
    Effects of serum thymic factor (FTS) on susceptibility of mice to PRV were also investigated.
  3. 03AnimalAnimal study (in vivo)Activity measurement

    In mice studied for FTS-induced resistance to PRV, FTS pretreatment enhanced natural killer cell activity.

    In plain wordsIn mice studied for resistance to PRV, FTS pretreatment increased natural killer cell activity.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    IncreaseNatural killer cell activity
    Study

    mousen: not reported in source

    PRV-infected mice
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Interferon production and NK cell activity were enhanced in the FTS-pretreated mice
    1 context sentence
    Summary · context
    Effects of serum thymic factor (FTS) on susceptibility of mice to PRV were also investigated.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.